General form of registration statement for all companies including face-amount certificate companies

SHAREHOLDERS' EQUITY - Stock Options (Details)

v3.22.0.1
SHAREHOLDERS' EQUITY - Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
Dec. 01, 2020
Jun. 30, 2020
Sep. 30, 2021
Dec. 31, 2020
Dec. 31, 2019
Share Capital          
Shares issued 16,357,703 156,032      
Common stock, shares issued     11,839,304 11,275,788 34,795,313
Common stock, shares outstanding     11,839,304 11,275,788 34,795,313
Stock options          
Share Capital          
Shares available for issuance       5,637,894  
Maximum percentage       10.00%  
Shares issued       3,743,000  
Common stock, shares issued       56,378,939  
Common stock, shares outstanding       56,378,939  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]          
Options at beginning of period (in shares)     3,743,000 3,186,000 3,335,000
Options granted (in shares)       865,000 1,501,000
Options exercised (in shares)       (50,000) (650,000)
Options canceled / expired (in shares)       (258,000) (1,000,000)
Options at end of period (in shares)     1,014,100 3,743,000 3,186,000
Options vested and exercisable as at end of the period     636,008 2,352,601  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]          
Exercise Price at beginning of period (in dollars per share)     $ 1.05 $ 1.12 $ 0.48
Options granted (in dollars per share)       0.95 1.56
Options exercised (in dollars per share)       0.50 0.15
Options canceled / expired (in dollars per share)       1.60 0.05
Exercise Price at end of period (in dollars per share)     5.16 1.05 $ 1.12
Exercise Price vested and exercisable (in dollars per share)     $ 4.93 $ 0.95  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]          
Weighted Average Remaining life (in years)     3 years 7 months 13 days 4 years 4 years 7 months 13 days
Weighted Average Remaining life vested and exercisable (in years)       3 years 11 months 23 days  
Aggregate Intrinsic Value       $ 1,053  
Aggregate Intrinsic Value vested and exercisable       $ 995